pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-5197 |
Genomic Coordinates | chr5: 143679860 - 143679971 |
Description | Homo sapiens miR-5197 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-5197-3p | ||||||||||||||||||
Sequence | 64| AAGAAGAGACUGAGUCAUCGAAU |86 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | TNRC6A | ||||||||||||||||||||
Synonyms | CAGH26, GW1, GW182, TNRC6 | ||||||||||||||||||||
Description | trinucleotide repeat containing 6A | ||||||||||||||||||||
Transcript | NM_014494 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on TNRC6A | |||||||||||||||||||||
3'UTR of TNRC6A (miRNA target sites are highlighted) |
>TNRC6A|NM_014494|3'UTR 1 CAGTGTAGATGCAGACTCACCGACCGGGACCTCAGACGCGAGGGAAAGGAGCACTAAGTGGGGCTCGCCGCCTGCAGCCA 81 GGGGCCGCCTGTGGGAACAGCTATTCTCTGCACATTTTCCACTTTGTTTTCCCCAAAACATATCAGTTTGAATACTTGAA 161 TCATGCAGGCCAATATTATAATGTGAAAAGGTATCTACTCTATTTACACTCCCAAATAGCGCCATACATGCTAAACCGTA 241 GAGAATGAGCTCGCTTGTGTCTATTCATCATGTTTAGCCTTTGGATTCTTTTTTTTTTTTTCCTTCTATTCCTCCCCAAC 321 CCCCCCCCCCGCCCCTTTTTTTCTCTCTTGCAAAACCATTTTTTGGGCTGATAACGTATGAGCTTTTCCCTTTGCACTGA 401 ATGATGTTCTCTCCGTCTCATCGGCAGTATGGGGGGCAGCTGTCCCAGTGTCAATGTTTACTCAAGGGTGTTCTTAGGAG 481 GCGTGCGCTCTCTACTATGCCTTGATGTTGCCTACCTTATTGTGGTATCGTGGAGTTTAAAAGATCAAGTTAGGATGCTG 561 ACTTAGGATTATTAATGAAAGTGTTGCACCAGTTTTTTCATGTTGTAAAACTAAAGAATTTCGCTCTGCAGTTTGAAAAA 641 CTGTGGCCACAGCTGTGACTTGCAGCCCACCTGCCACCCAGGACGGGCCCTGCACTTTGAATAGGCTTTCCATTTTGTTT 721 TGGAGGTTCTCACTTTGAACCTTCTTGTTTACAGATTTTTTTGTTTGTTTTTTGAGAAAAAAAAATGTTTACTCTTCCAT 801 CATTTAAAAAAAATGTAAAAGACAAAAAAAAAATGGAGGATGATTTAAAAGATGCTTTCTATCTCTGGGAAAAAGGAGCA 881 GCATTTGGCCATGTTCTTTTGTTTTTCTATTCCTGTCCCAAATCAAAGAGCATGGTTCTCAGGAAAACCAGTTCCCCAGT 961 TTAAAAAAAAAAAAAAAAATTCCTTGTAGTTTCTTAGAGGAAAAAAAGAAAAACCCCAACTTTTAGCACTGATACTACAT 1041 ATTGCTCTGTTAAAGAATTTTCTCTGCCAAAAAAAAAGAAAAAACAAAAAAACGCTTAAAGCTGGAGTTTGACATTCTGC 1121 TTTCAGATGCTGTCTTTTTATTAGTGAGTGATGATGGTTTGCTAATAATCAATAGGTAATAATTTTTTGTAATCCCATCA 1201 AGTGGCTCCATATGTTTCTGCTCTCTCGTGACTGTGTTAATGTTTAACTGTTGTACCTTAAAGCCGAAATCAGTAACTAT 1281 GCATACTGTAACCAAGGTATTGGGCTTACAGAGTTGTTTGTTGTATAAAGAAAATTTTAAATGTTGTTGCAAACTAACGA 1361 GTTACACCATTTTAAACTTTCTTTCCTCCCCCCTTTTTTTGCCCACAAATGGTATTATAATGCTTGCTTAGTCAAAGAAG 1441 AGAGACTAAACAAGGGTAAAAATTTTAACAGTACAGAATTTGCCATCATATCATTGCCTTGATTCTAACTGTTTGTGTCC 1521 TAAGATGCAAAAGAAGTCAGTGGCTTTTAACTGTTTACAAATAGAATGTGATTGTAAAATGTACAGTTTGGTTGTGTTTG 1601 AATTATGAAATTTCTTCAGATATAATAAACCATGACTTTTTGGCTGCTCAACATTAATTGTCTCCTTTTTGTGAATTTAT 1681 TTGTAGGCTCTTTTTTATAATGAAAGTTTCAAAGTTGCTATGTATGAGGGTTCTCATAGAGCAACCGATTAAAAATCTAA 1761 GCAAATATTTGAACATTTTATCTGAACTCATCACAATTTCACCCTGAAATAATGTGAGAACAATGGGAAACTGTAGCTTG 1841 CTCCTTCCCACCCTCTCTGAGCATCTTTGGGATCTTGTTGCTCAAAACTCTTCTGTGACTTCATCTTCCCCACCATTTGT 1921 GCCCATCTCAAGCCTCAGCAAGAAACCATGTGGAACATGAAGCTTAATGACTTGACAGTGTACTAGTGTTAAACTCTCAT 2001 ACCTCTGTTACAAAGCGAGAAACGCCACACCCGGACTGGCCTTTTCTTCCCCCTTCACGGCCCTCGCTTCTCCCTGCAGG 2081 AGCTCGGGGGCGAAACCTGTGTATGGATTTCAGTGTATGACTTCAGATCATGCTCCAACTTGCCAGGTGTGAGCTAATGT 2161 TGTCGGACACCTTACTATAAGCAAATGTTATTCAGTGCGTTCAATGTATATTGACTTCCATACTGGTTTTTCCAAAAACC 2241 AAAGGTAGCTTTGAAAAACCATGTCTGGAAATGTTTGGAGCGTTAAGCTGATTGACCTTCTGACCTTGGGGCTTTGAGTA 2321 GTATATAATTCATAACTGCGTTAATTGTATTGTTAAAGTGTTTGGGAGTTTTTTGCGCTTGTTATGTGGAAATAAAGTGT 2401 TTGATTTAAAATTTTTTAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | MCF7 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
CLIP-seq Support 1 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000395799.3 | 3UTR | CUCAAAACUCUUCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
130 hsa-miR-5197-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT055372 | PDCD4 | programmed cell death 4 | 2 | 4 | ||||||||
MIRT063381 | ETNK1 | ethanolamine kinase 1 | 2 | 2 | ||||||||
MIRT068048 | SAP18 | Sin3A associated protein 18 | 2 | 6 | ||||||||
MIRT070247 | FRMD6 | FERM domain containing 6 | 2 | 2 | ||||||||
MIRT088320 | RAB10 | RAB10, member RAS oncogene family | 2 | 4 | ||||||||
MIRT097550 | VCAN | versican | 2 | 2 | ||||||||
MIRT130055 | TRAF6 | TNF receptor associated factor 6 | 2 | 2 | ||||||||
MIRT164190 | SCOC | short coiled-coil protein | 2 | 2 | ||||||||
MIRT183552 | BTG2 | BTG anti-proliferation factor 2 | 2 | 4 | ||||||||
MIRT194954 | TNRC6A | trinucleotide repeat containing 6A | 2 | 2 | ||||||||
MIRT199034 | POLI | DNA polymerase iota | 2 | 2 | ||||||||
MIRT200619 | BCL3 | B-cell CLL/lymphoma 3 | 2 | 2 | ||||||||
MIRT231349 | SERPINH1 | serpin family H member 1 | 2 | 2 | ||||||||
MIRT243305 | SLC25A36 | solute carrier family 25 member 36 | 2 | 2 | ||||||||
MIRT270950 | GPRC5A | G protein-coupled receptor class C group 5 member A | 2 | 2 | ||||||||
MIRT295297 | BTBD3 | BTB domain containing 3 | 2 | 6 | ||||||||
MIRT295775 | MAPRE1 | microtubule associated protein RP/EB family member 1 | 2 | 2 | ||||||||
MIRT297115 | GCC2 | GRIP and coiled-coil domain containing 2 | 2 | 6 | ||||||||
MIRT333632 | ZFP91 | ZFP91 zinc finger protein | 2 | 2 | ||||||||
MIRT338923 | HMGN2 | high mobility group nucleosomal binding domain 2 | 2 | 2 | ||||||||
MIRT344878 | WIPF2 | WAS/WASL interacting protein family member 2 | 2 | 2 | ||||||||
MIRT352038 | BZW1 | basic leucine zipper and W2 domains 1 | 2 | 4 | ||||||||
MIRT360289 | HIST1H3E | histone cluster 1 H3 family member e | 2 | 2 | ||||||||
MIRT362931 | CLDN12 | claudin 12 | 2 | 2 | ||||||||
MIRT375251 | MAPK8IP3 | mitogen-activated protein kinase 8 interacting protein 3 | 2 | 4 | ||||||||
MIRT405442 | RAB5B | RAB5B, member RAS oncogene family | 2 | 2 | ||||||||
MIRT442511 | OSBP | oxysterol binding protein | 2 | 2 | ||||||||
MIRT443281 | TSPAN15 | tetraspanin 15 | 2 | 2 | ||||||||
MIRT443379 | PLXNA2 | plexin A2 | 2 | 2 | ||||||||
MIRT443900 | NUTM2E | NUT family member 2E | 2 | 2 | ||||||||
MIRT445537 | MOG | myelin oligodendrocyte glycoprotein | 2 | 2 | ||||||||
MIRT446235 | C17orf80 | chromosome 17 open reading frame 80 | 2 | 2 | ||||||||
MIRT446962 | ZNF431 | zinc finger protein 431 | 2 | 2 | ||||||||
MIRT447545 | RNF165 | ring finger protein 165 | 2 | 2 | ||||||||
MIRT447686 | MTPAP | mitochondrial poly(A) polymerase | 2 | 2 | ||||||||
MIRT450499 | LIMD2 | LIM domain containing 2 | 2 | 2 | ||||||||
MIRT451257 | ZNF444 | zinc finger protein 444 | 2 | 2 | ||||||||
MIRT453934 | COMMD5 | COMM domain containing 5 | 2 | 4 | ||||||||
MIRT454042 | DDT | D-dopachrome tautomerase | 2 | 2 | ||||||||
MIRT454549 | RABL2A | RAB, member of RAS oncogene family like 2A | 2 | 2 | ||||||||
MIRT456455 | TMEM81 | transmembrane protein 81 | 2 | 2 | ||||||||
MIRT456546 | TMEM63A | transmembrane protein 63A | 2 | 2 | ||||||||
MIRT456614 | SFMBT2 | Scm like with four mbt domains 2 | 2 | 2 | ||||||||
MIRT456634 | ARMCX6 | armadillo repeat containing, X-linked 6 | 2 | 2 | ||||||||
MIRT457258 | RABL2B | RAB, member of RAS oncogene family like 2B | 2 | 2 | ||||||||
MIRT458092 | C8orf33 | chromosome 8 open reading frame 33 | 2 | 2 | ||||||||
MIRT458210 | FOXL2 | forkhead box L2 | 2 | 2 | ||||||||
MIRT458459 | RPRM | reprimo, TP53 dependent G2 arrest mediator homolog | 2 | 2 | ||||||||
MIRT458700 | LEPREL1 | prolyl 3-hydroxylase 2 | 1 | 1 | ||||||||
MIRT461649 | ZSWIM4 | zinc finger SWIM-type containing 4 | 2 | 2 | ||||||||
MIRT461996 | PACSIN1 | protein kinase C and casein kinase substrate in neurons 1 | 2 | 2 | ||||||||
MIRT462237 | PRSS16 | protease, serine 16 | 2 | 2 | ||||||||
MIRT464774 | UBE2G1 | ubiquitin conjugating enzyme E2 G1 | 2 | 2 | ||||||||
MIRT465051 | TTC14 | tetratricopeptide repeat domain 14 | 2 | 2 | ||||||||
MIRT465393 | TPD52L2 | tumor protein D52 like 2 | 2 | 2 | ||||||||
MIRT467612 | SLC7A5 | solute carrier family 7 member 5 | 2 | 2 | ||||||||
MIRT467938 | SLC16A6 | solute carrier family 16 member 6 | 2 | 2 | ||||||||
MIRT470022 | PTP4A2 | protein tyrosine phosphatase type IVA, member 2 | 2 | 2 | ||||||||
MIRT470049 | PTGFRN | prostaglandin F2 receptor inhibitor | 2 | 2 | ||||||||
MIRT470514 | PPP1R11 | protein phosphatase 1 regulatory inhibitor subunit 11 | 2 | 2 | ||||||||
MIRT471073 | PIM2 | Pim-2 proto-oncogene, serine/threonine kinase | 2 | 2 | ||||||||
MIRT471610 | PAQR5 | progestin and adipoQ receptor family member 5 | 2 | 18 | ||||||||
MIRT472026 | NPM1 | nucleophosmin 1 | 2 | 2 | ||||||||
MIRT474358 | KMT2D | lysine methyltransferase 2D | 2 | 2 | ||||||||
MIRT474681 | KLF10 | Kruppel like factor 10 | 2 | 2 | ||||||||
MIRT474878 | KDELR1 | KDEL endoplasmic reticulum protein retention receptor 1 | 2 | 2 | ||||||||
MIRT477137 | FAM107B | family with sequence similarity 107 member B | 2 | 6 | ||||||||
MIRT477850 | DYRK3 | dual specificity tyrosine phosphorylation regulated kinase 3 | 2 | 2 | ||||||||
MIRT477922 | DUSP2 | dual specificity phosphatase 2 | 2 | 2 | ||||||||
MIRT479772 | CCND1 | cyclin D1 | 2 | 2 | ||||||||
MIRT480108 | CALR | calreticulin | 2 | 2 | ||||||||
MIRT482161 | AK2 | adenylate kinase 2 | 2 | 2 | ||||||||
MIRT482232 | AHCYL2 | adenosylhomocysteinase like 2 | 2 | 2 | ||||||||
MIRT483455 | ARHGEF6 | Rac/Cdc42 guanine nucleotide exchange factor 6 | 2 | 4 | ||||||||
MIRT487256 | KHSRP | KH-type splicing regulatory protein | 2 | 2 | ||||||||
MIRT488677 | SPAM1 | sperm adhesion molecule 1 | 2 | 2 | ||||||||
MIRT488930 | GFRAL | GDNF family receptor alpha like | 2 | 2 | ||||||||
MIRT489980 | DDB1 | damage specific DNA binding protein 1 | 2 | 2 | ||||||||
MIRT492360 | SEMA7A | semaphorin 7A (John Milton Hagen blood group) | 2 | 2 | ||||||||
MIRT493688 | HAP1 | huntingtin associated protein 1 | 2 | 2 | ||||||||
MIRT497165 | BBX | BBX, HMG-box containing | 2 | 2 | ||||||||
MIRT498884 | ZNF12 | zinc finger protein 12 | 2 | 10 | ||||||||
MIRT500182 | CHRM3 | cholinergic receptor muscarinic 3 | 2 | 2 | ||||||||
MIRT501904 | MED13 | mediator complex subunit 13 | 2 | 2 | ||||||||
MIRT505903 | RIMS3 | regulating synaptic membrane exocytosis 3 | 2 | 6 | ||||||||
MIRT506597 | MECP2 | methyl-CpG binding protein 2 | 2 | 4 | ||||||||
MIRT508945 | AK4 | adenylate kinase 4 | 2 | 4 | ||||||||
MIRT510650 | TMEM167A | transmembrane protein 167A | 2 | 4 | ||||||||
MIRT512847 | A1CF | APOBEC1 complementation factor | 2 | 6 | ||||||||
MIRT514490 | SLPI | secretory leukocyte peptidase inhibitor | 2 | 4 | ||||||||
MIRT520637 | NPM3 | nucleophosmin/nucleoplasmin 3 | 2 | 6 | ||||||||
MIRT528919 | TOMM20 | translocase of outer mitochondrial membrane 20 | 2 | 6 | ||||||||
MIRT529866 | DGAT1 | diacylglycerol O-acyltransferase 1 | 2 | 2 | ||||||||
MIRT533359 | UBE2W | ubiquitin conjugating enzyme E2 W | 2 | 2 | ||||||||
MIRT534688 | RNF125 | ring finger protein 125 | 2 | 2 | ||||||||
MIRT535930 | MIER1 | MIER1 transcriptional regulator | 2 | 2 | ||||||||
MIRT538253 | CUL3 | cullin 3 | 2 | 4 | ||||||||
MIRT546021 | WDR26 | WD repeat domain 26 | 2 | 4 | ||||||||
MIRT547354 | NAT8L | N-acetyltransferase 8 like | 2 | 2 | ||||||||
MIRT549430 | ACVR1 | activin A receptor type 1 | 2 | 2 | ||||||||
MIRT551488 | TMEM192 | transmembrane protein 192 | 2 | 4 | ||||||||
MIRT554624 | RPS6KA3 | ribosomal protein S6 kinase A3 | 2 | 2 | ||||||||
MIRT560155 | MOB1A | MOB kinase activator 1A | 2 | 2 | ||||||||
MIRT560447 | ALG14 | ALG14, UDP-N-acetylglucosaminyltransferase subunit | 2 | 2 | ||||||||
MIRT560711 | ZNF324B | zinc finger protein 324B | 2 | 2 | ||||||||
MIRT560962 | WRN | Werner syndrome RecQ like helicase | 2 | 2 | ||||||||
MIRT563870 | FAM206A | family with sequence similarity 206 member A | 2 | 2 | ||||||||
MIRT564138 | ZNF689 | zinc finger protein 689 | 2 | 2 | ||||||||
MIRT568121 | CDC27 | cell division cycle 27 | 2 | 2 | ||||||||
MIRT568141 | CCDC88C | coiled-coil domain containing 88C | 2 | 2 | ||||||||
MIRT568285 | BCOR | BCL6 corepressor | 2 | 2 | ||||||||
MIRT568469 | ARMC12 | armadillo repeat containing 12 | 2 | 2 | ||||||||
MIRT569742 | GPR173 | G protein-coupled receptor 173 | 2 | 2 | ||||||||
MIRT570175 | LIPG | lipase G, endothelial type | 2 | 2 | ||||||||
MIRT570545 | RPH3A | rabphilin 3A | 2 | 2 | ||||||||
MIRT570952 | CPE | carboxypeptidase E | 2 | 2 | ||||||||
MIRT572800 | SIGLEC14 | sialic acid binding Ig like lectin 14 | 2 | 2 | ||||||||
MIRT573114 | ERBB2IP | erbb2 interacting protein | 2 | 2 | ||||||||
MIRT574212 | SDCBP | syndecan binding protein | 2 | 2 | ||||||||
MIRT574662 | KIF5B | kinesin family member 5B | 2 | 2 | ||||||||
MIRT662448 | SERPINB5 | serpin family B member 5 | 2 | 2 | ||||||||
MIRT695768 | C4orf33 | chromosome 4 open reading frame 33 | 2 | 2 | ||||||||
MIRT705832 | AIFM2 | apoptosis inducing factor, mitochondria associated 2 | 2 | 2 | ||||||||
MIRT712185 | SRSF10 | serine and arginine rich splicing factor 10 | 2 | 2 | ||||||||
MIRT712996 | CDV3 | CDV3 homolog | 2 | 2 | ||||||||
MIRT714411 | ZNF706 | zinc finger protein 706 | 2 | 2 | ||||||||
MIRT719226 | CAMK4 | calcium/calmodulin dependent protein kinase IV | 2 | 2 | ||||||||
MIRT720279 | EIF1AD | eukaryotic translation initiation factor 1A domain containing | 2 | 2 | ||||||||
MIRT720946 | PPP1R3E | protein phosphatase 1 regulatory subunit 3E | 2 | 2 | ||||||||
MIRT723201 | KLHDC10 | kelch domain containing 10 | 2 | 2 |